In the 12 months to Nov 8, 2026, on the open market: sold $3.6M of TRDA. Filed a median of 1 business day after the trade.
Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these
Insider purchases above the line: $0Insider sales below: $3.6M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
TRDASold: Entrada Therapeutics, Inc. Sep 9, 202628,837 sharesfiled Sep 9, 20263,885,115 shares held indirectly after, as filedfiling$206K
TRDASold: Entrada Therapeutics, Inc. Sep 8, 2026192,500 sharesfiled Sep 9, 20263,913,952 shares held indirectly after, as filedfiling$1.4M
TRDASold: Entrada Therapeutics, Inc. Sep 4, 202638,500 sharesfiled Sep 9, 20264,106,452 shares held indirectly after, as filedfiling$274K
TRDASold: Entrada Therapeutics, Inc. Sep 3, 202632,263 sharesfiled Sep 3, 20264,144,952 shares held indirectly after, as filedfiling$231K
TRDASold: Entrada Therapeutics, Inc. Sep 2, 202625,131 sharesfiled Sep 3, 20264,177,215 shares held indirectly after, as filedfiling$181K
TRDASold: Entrada Therapeutics, Inc. Sep 1, 202629,088 sharesfiled Sep 3, 20264,202,346 shares held indirectly after, as filedfiling$205K
TRDASold: Entrada Therapeutics, Inc. Aug 31, 202644,259 sharesfiled Aug 31, 20264,231,434 shares held indirectly after, as filedfiling$309K
TRDASold: Entrada Therapeutics, Inc. Aug 28, 20263,733 sharesfiled Aug 31, 20264,275,693 shares held indirectly after, as filedfiling$26K
TRDASold: Entrada Therapeutics, Inc. Aug 27, 202638,922 sharesfiled Aug 31, 20264,279,426 shares held indirectly after, as filedfiling$280K
TRDASold: Entrada Therapeutics, Inc. Aug 26, 202614,569 sharesfiled Aug 26, 20264,318,348 shares held indirectly after, as filedfiling$103K
TRDASold: Entrada Therapeutics, Inc. Aug 25, 202626,522 sharesfiled Aug 26, 20264,332,917 shares held indirectly after, as filedfiling$200K
TRDASold: Entrada Therapeutics, Inc. Aug 24, 202621,623 sharesfiled Aug 26, 20264,359,439 shares held indirectly after, as filedfiling$159K
Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.
